News
Global Access Diagnostics (GADx) selected as member of ARPA-H Investor Catalyst Hub spoke network
Global Access Diagnostics (GADx) has been selected as a spoke for the Investor Catalyst Hub, a regional hub of ARPANET-H, a nationwide health innovation network launched by the Advanced Research Projects Agency for Health (ARPA-H). …
Botswana, a major animal health player on the African Continent
In 2023, Botswana hosted the 25th World Organization for Animal Health (WOAH) Regional Commission for Africa conference in Gaborone. At the opening of the event, the Botswana Institute for Technology Research and Innovation (BITRI) presented…
GHLabs x GADx: PoC innovation in molecular diagnostics
The sensitivity of molecular testing is now being revolutionised for point-of-care (PoC) usage. PCR, known for its high sensitivity and specificity, is the gold standard in diagnosing many infectious diseases. However, its availability has been…
Botrytis: How on-site diagnostics can support the wine industry
Botrytis bunch rot is a disease that still afflicts the wine industry. An estimated 25% of the globe’s $66 billion worth of wine grapes produced annually lost due to this disease! This article provides an in-depth look…
Liver fluke test: Developing a rapid test to support farmers in response to antihelminthic resistance
“We are delighted that what started as a research tool is now being developed as a practical diagnostic test for farmers and vets, to support strategic control for this common, devastating disease.” Dr Tessa Walsh,…
New CEO at GADx, Dr Mark Street-Docherty
It is with great pleasure that Mologic Ltd t/a Global Access Diagnostics (GADx), announces the appointment of our new CEO, starting 1st February 2024, Dr Mark Street-Docherty. Mark brings with him enormous experience of leading…
How in-field diagnostics can reduce waste on farms and promote sustainable agriculture
Did you know that on a global scale up to 40% of crops are lost to pests and diseases? This article provides an overview on the waste associated with farming, contributing to global food insecurity,…
GADx reintroduces IT LEISH, the rapid diagnostic test for visceral leishmaniasis
Global Access Diagnostics (GADx), a social enterprise prioritising equitable access to diagnostics, today announced the launch of IT LEISH, a rapid diagnostic test (RDT) for visceral leishmaniasis (VL). The company acquired the manufacturing rights for…
COVID-19 Rapid Antigen Self-Test, COVI-Go™, receives FDA Emergency Use Authorization for home use
Mologic Inc., the US subsidiary of Global Access Diagnostics (GADx), a leading developer of lateral flow and rapid diagnostic technologies, products and services, announced today that its proprietary COVI-Go™ SARS-CoV-2 Ag Self-Test received Emergency Use…
Detecting multiple diseases at once: EU-funded DIDIDA project develops a cost-effective mobile based solution in Africa
The Digital Innovations and Diagnostics for Infectious Diseases in Africa (DIDIDA) had its official kick-off at the Strathmore University. DIDIDA is an ambitious project to develop reliable, low-cost, mobile phone-connected tests to help detect multiple…